![]() |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Sunday, July 6, 2008
|
Drug-induced immune hemolytic anemiaDefinitionDrug-induced immune hemolytic anemia is a blood disorder that occurs when a medicine tells the body's defensive (immune) system to attack red blood cells. It causes red blood cells to break down earlier than normal. See also: Hemolytic anemia Alternative NamesImmune hemolytic anemia secondary to drugs; Anemia - immune hemolytic - secondary to drugsCausesDrug-induced immune hemolytic anemia occurs when a drug causes your body's immune system to react against red blood cells. In some cases, a drug can cause the immune system to mistakenly think the red blood cells are dangerous, foreign substances. Antibodies form against the red blood cells. The antibodies attach to red blood cells and cause them to break down too early. Drugs that can cause this type of hemolytic anemia include:
There are many other rarer causes of drug-induced hemolytic anemia. Drug-induced hemolytic anemia is associated with G6PD deficiency. But in this case, the breakdown of red blood cells is due to a certain type of stress in the cell, not the body's immune system. Drug-induced hemolytic anemia is rare in children. Symptoms
Exams and TestsA physical examination may show an enlarged spleen. A number of blood and urine tests may be done to help diagnose this condition.
TreatmentStopping the drug that is causing the problem may relieve or control the symptoms. Some persons may be given a medicine called prednisone. Special blood transfusions may be needed to treat severe symptoms. Outlook (Prognosis)Most patients have a good outcome. Possible ComplicationsDeath caused by severe anemia rarely occurs. Transfusion can cause a transfusion reaction. When to Contact a Medical ProfessionalSee your health care provider if you have symptoms of this condition. PreventionYou should continue to avoid the drug that caused this condition. Vandendries ER. Drug-associated disease: hematologic dysfunction. Crit Care Clin. April 2006; 22(2): 347-55, viii. Dhaliwal G. Hemolytic anemia. Am Fam Physician. June 2004; 69(11): 2599-606. Kasper D, Braunwald E, Fauci A, et al. Harrison's Principals of Internal Medicine. 16th edition [online version]. New York, NY: McGraw Hill; 2005.
Review Date: 4/1/2007 Reviewed By: Mark Levin, MD, Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited. |